Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

Background. Specific antiretroviral therapy (ART) medications and the severity of human immunodeficiency virus (HIV) disease before treatment contribute to bone mineral density (BMD) loss after ART initiation. Methods. We compared the percentage change in BMD over 96 weeks in 328 HIV-infected, treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Brown, Todd T., Moser, Carlee, Currier, Judith S., Ribaudo, Heather J., Rothenberg, Jennifer, Kelesidis, Theodoros, Yang, Otto, Dubé, Michael P., Murphy, Robert L., Stein, James H., McComsey, Grace A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577040/
https://ncbi.nlm.nih.gov/pubmed/25948863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados